Trial intelligence / Profile preview

Oral Lactulose vs Standard PEG for Bowel Preparation

NCT04794049Unknown

Sponsor
Hangzhou First People's Hospital
Start
May 2021
Primary completion
Oct 2021
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
01

Overview

Randomised, open-label trial of lactulose (2 cohorts), sponsored by Hangzhou First People's Hospital. Primary endpoint: Bowel preparation quality at 2 hours. Status: unknown.

02

Drugs

lactulose

Beyond the preview

Go deeper on NCT04794049.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04794049.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call